Page last updated: 2024-12-08

acetyltaurine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

acetyltaurine: used in the treatment of magnesium deficiency [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

acetyltaurine : An amino sulfonic acid that is taurine substituted by an acetyl group at the N atom. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID159864
CHEBI ID84415
SCHEMBL ID468761
MeSH IDM0221151

Synonyms (21)

Synonym
acetyltaurinate
19213-70-8
2-acetamidoethanesulfonic acid
n-acetyltaurine
magnesium acetyltaurate
atamg ,
magnesium acetyltaurinate
unii-ul4h5mx8b7
taurine, n-acetyl-
ul4h5mx8b7 ,
acetyltaurine
AKOS025296233
CHEBI:84415
2-(acetylamino)ethanesulfonic acid
SCHEMBL468761
DTXSID80172779
Q27157742
2-acetamidoethane-1-sulfonic acid
(2-acetylamino)ethanesulfonic acid
ethanesulfonic acid, 2-(acetylamino)-
n-acetyl taurine

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The toxic effects of glutamate on RGCs are mediated by the overstimulation of N-methyl-D-aspartate (NMDA) receptors."( Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina.
Agarwal, P; Agarwal, R; Arfuzir, NN; Bakar, NS; Iezhitsa, I; Ismail, NM; Jafri, AJ; Krasilnikova, A; Kutty, MK; Lambuk, L; Ozerov, A; Rozali, KN; Spasov, A; Yusof, AP, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human urinary metaboliteAny metabolite (endogenous or exogenous) found in human urine samples.
human blood serum metaboliteAny metabolite (endogenous or exogenous) found in human blood serum samples.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
acetamidesCompounds with the general formula RNHC(=O)CH3.
organosulfonic acidAn organic derivative of sulfonic acid in which the sulfo group is linked directly to carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (13.33)18.2507
2000's1 (6.67)29.6817
2010's10 (66.67)24.3611
2020's2 (13.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.00 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index5.76 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (5.88%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]